Literature DB >> 11451280

Effect of essential hypertension on cardiac autonomic function in type 2 diabetic patients.

N Takahashi1, M Nakagawa, T Saikawa, T Ooie, K Yufu, S Shigematsu, M Hara, H Sakino, I Katsuragi, T Okeda, H Yoshimatsu, T Sakata.   

Abstract

OBJECTIVES: The aim of this study was to examine the effects of essential hypertension on cardiac autonomic function in type 2 diabetic patients.
BACKGROUND: Hypertension is common in type 2 diabetic patients and is associated with a high mortality. However, the combined effects of type 2 diabetes and essential hypertension on cardiac autonomic function have not been fully elucidated.
METHODS: Thirty-three patients with type 2 diabetes were assigned to a hypertensive diabetic group (n = 15; age: 56 +/- 8 years, mean +/- SD) or an age-matched normotensive diabetic group (n = 18, 56 +/- 6 years). Cardiac autonomic function was assessed by baroreflex sensitivity (BRS), heart rate variability (HRV), plasma norepinephrine concentration and cardiac 123I-metaiodobenzylguanidine (MIBG) scintigraphic findings.
RESULTS: Baroreflex sensitivity was lower in the hypertensive diabetic group than it was in the normotensive diabetic group (p < 0.05). The early and delayed myocardial uptake of 123I-MIBG was lower (p < 0.01 and p < 0.05, respectively), and the percent washout rate of 123I-MIBG was higher (p < 0.05) in the hypertensive diabetic group. However, the high frequency (HF) power and the ratio of low frequency (LF) power to HF power (LF/HF) of HRV and plasma norepinephrine concentration were not significantly different. The homeostasis model assessment index was higher in the hypertensive diabetic group than it was in the normotensive diabetic group (p < 0.01).
CONCLUSIONS: Our results indicate that essential hypertension acts synergistically with type 2 diabetes to depress cardiac reflex vagal and sympathetic function, and the results also suggest that insulin resistance may play a pathogenic role in these processes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451280     DOI: 10.1016/s0735-1097(01)01363-8

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  Homocysteine levels are associated with the results of 123I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.

Authors:  Futoshi Anan; Hidetoshi Yonemochi; Takayuki Masaki; Naohiko Takahashi; Mikiko Nakagawa; Nobuoki Eshima; Tetsunori Saikawa; Hironobu Yoshimatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08-04       Impact factor: 9.236

2.  Alterations of calcium channels and cell excitability in intracardiac ganglion neurons from type 2 diabetic rats.

Authors:  Jinxu Liu; Huiyin Tu; Hong Zheng; Libin Zhang; Thai P Tran; Robert L Muelleman; Yu-Long Li
Journal:  Am J Physiol Cell Physiol       Date:  2011-12-21       Impact factor: 4.249

3.  Cardiovascular reactivity and cardiometabolic risk in adolescents.

Authors:  Amanda J Countryman; Patrice G Saab; Neil Schneiderman; Judith R McCalla; Maria M Llabre
Journal:  Int J Behav Med       Date:  2014-02

4.  Cardiac autonomic neuropathy in patients with diabetes and no symptoms of coronary artery disease: comparison of 123I-metaiodobenzylguanidine myocardial scintigraphy and heart rate variability.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Victoria Delgado; Jurriaan A Kok; Mieke T J Bus; Arie C Maan; Marcel P Stokkel; Antje V Kharagitsingh; Petra Dibbets-Schneider; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-22       Impact factor: 9.236

5.  Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.

Authors:  Shigeki Nagamachi; Seigo Fujita; Ryuichi Nishii; Shigemi Futami; Shozo Tamura; Masanari Mizuta; Masamitsu Nakazato; Takeshi Kurose; Hideyuki Wakamatsu
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

6.  Insulin restores myocardial presynaptic sympathetic neuronal integrity in insulin-resistant diabetic rats.

Authors:  James T Thackeray; Robert A deKemp; Rob S Beanlands; Jean N DaSilva
Journal:  J Nucl Cardiol       Date:  2013-07-11       Impact factor: 5.952

7.  Altered sympathetic nervous system signaling in the diabetic heart: emerging targets for molecular imaging.

Authors:  James T Thackeray; Rob S Beanlands; Jean N Dasilva
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-20

8.  Sensitivity of temporal heart rate variability in Poincaré plot to changes in parasympathetic nervous system activity.

Authors:  Chandan K Karmakar; Ahsan H Khandoker; Andreas Voss; Marimuthu Palaniswami
Journal:  Biomed Eng Online       Date:  2011-03-03       Impact factor: 2.819

9.  New squatting test indices are useful for assessing baroreflex sensitivity in diabetes mellitus.

Authors:  M Nakagawa; T Shinohara; F Anan; K Yufu; N Takahashi; N Okada; M Hara; H Yoshimatsu; T Saikawa
Journal:  Diabet Med       Date:  2008-11       Impact factor: 4.359

10.  Abdominal visceral fat accumulation is associated with the results of (123)I-metaiodobenzylguanidine myocardial scintigraphy in type 2 diabetic patients.

Authors:  Futoshi Anan; Takayuki Masaki; Hidetoshi Yonemochi; Naohiko Takahashi; Mikiko Nakagawa; Nobuoki Eshima; Tetsunori Saikawa; Hironobu Yoshimatsu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04-06       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.